Inhaled corticosteroids in COPD: quantifying risks and benefits

被引：19

|

作者：

Cates, Chris ^{[1
]}

机构：

[1] SGUL, London SW17 0RE, England

来源：

THORAX | 2013年 / 68卷 / 06期

关键词：

FLUTICASONE PROPIONATE/SALMETEROL 250/50; EXACERBATIONS; SALMETEROL;

D O I：

10.1136/thoraxjnl-2012-202959

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

收藏

页码：499 / 500

页数：2

相关论文

共 50 条

[1] Q/What are the benefits and risks of inhaled corticosteroids for COPD?
Hamilton, Tanya
Miller, John B.
Vincent, E. Chris
St Anna, Leilani
JOURNAL OF FAMILY PRACTICE, 2014, 63 (05): : 275 - 278
[2] Inhaled corticosteroids: Benefits and risks
Robinson, DS
Geddes, DM
JOURNAL OF ASTHMA, 1996, 33 (01) : 5 - 16
[3] INHALED CORTICOSTEROIDS - BENEFITS AND RISKS
GEDDES, DM
THORAX, 1992, 47 (06) : 404 - 407
[4] INHALED CORTICOSTEROIDS - BENEFITS AND RISKS
SMITH, BJ
THORAX, 1992, 47 (12) : 1084 - 1084
[5] Benefits and risks of inhaled corticosteroids
Graft, DF
ASTHMA: FROM GENES TO CLINICAL MANAGEMENT, 2003, : 39 - 46
[6] Inhaled corticosteroids in COPD: risk and benefits
Janson, Christer
THORAX, 2022, 77 (06) : 530 - 531
[7] Weighing the benefits and risks of inhaled corticosteroids
Varkey, Basil
CURRENT OPINION IN PULMONARY MEDICINE, 2007, 13 (02) : 89 - 89
[8] Dose response to inhaled corticosteroids: Benefits and risks
Lipworth, BJ
Wilson, AM
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 19 (06) : 625 - 646
[9] Risks and Benefits of Periodic Treatment of Asthma with Inhaled Corticosteroids
Constant P. van Schayck
BioDrugs, 1997, 7 : 1 - 5
[10] Risks and benefits of periodic treatment of asthma with inhaled corticosteroids
vanSchayck, CP
BIODRUGS, 1997, 7 (01) : 1 - 5

← 1 2 3 4 5 →